Electrochemotherapy in the Management of Keratinocyte Carcinomas: A Systematic Review
Cancers · 24.05.2025 · 17 (11) · 1766
DOI: 10.3390/cancers17111766 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 24.05.2025. Verfasst von Yue Ting Nichole Tan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Duke-NUS Medical School, Singapore 169857, Singapore. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Keratinocyte carcinomas, including basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), presents a growing concern. Electrochemotherapy (ECT), an emerging treatment modality, combines chemotherapy and electroporation to enhance drug delivery into cells. However, reviews evaluating ECT in keratinocyte carcinomas are lacking.
Objectives
This study reviews the efficacy and toxicity of ECT in the treatment and palliation of keratinocyte carcinomas.
Methods
A systematic search was conducted across PubMed, Cochrane, Embase, and Scopus databases. Patient, tumor, and treatment characteristics, tumor response, long-term disease outcomes, and toxicity data were extracted. Quality of studies was assessed using validated tools. Primary endpoints included tumor response; secondary endpoints included long-term disease outcomes and toxicity.
Results
Twenty-one studies were included. Complete response (CR) rates ranged from 50 to 100% and from 10 to 100% for BCC and SCC, respectively. OS rates ranged from 95 (14 months) to 100 (1 year) % and from 64 (1 year) to 85.1 (8.6 months) % for BCC and SCC, respectively. One-year local disease-free survival (LDFS) rates were 89% and 87% for BCC and SCC, respectively. For BCC, local progression-free survival (LPFS) rates were 96% (1 year), 90% (2 year), and 70% (5 year). For SCC, 1-year LPFS rates were 80% on a per-patient basis and 49% on a per-lesion basis.
Conclusions
ECT is effective and tolerable in the treatment and palliation of keratinocyte carcinomas. Future studies should focus on improving reporting quality, optimizing treatment protocols, and investigating long-term outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Duke-NUS Medical School, Singapore 169857, Singapore.
- Department of Dermatology, Singapore General Hospital, Singapore 169608, Singapore.
ORCID-Profile: Yue Ting Nichole Tan, Choon Chiat Oh
Zitieren
APA
Tan, Y. T. N., & Oh, C. C. (2025). Electrochemotherapy in the Management of Keratinocyte Carcinomas: A Systematic Review. Cancers, 17(11), 1766. https://doi.org/10.3390/cancers17111766
Vancouver
Tan YTN, Oh CC. Electrochemotherapy in the Management of Keratinocyte Carcinomas: A Systematic Review. Cancers. 2025;17(11):1766. doi:10.3390/cancers17111766
BibTeX
@article{Tan2025,
author = {Tan, Yue Ting Nichole and Oh, Choon Chiat},
title = {Electrochemotherapy in the Management of Keratinocyte Carcinomas: A Systematic Review},
journal = {Cancers},
year = {2025},
volume = {17},
number = {11},
pages = {1766},
doi = {10.3390/cancers17111766}
}
EUVIMED